振邦智能(003028) - 2023 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2023 was ¥213,051,602.08, a decrease of 25.91% compared to ¥287,553,976.89 in the same period last year[5] - Net profit attributable to shareholders was ¥22,831,022.41, down 46.28% from ¥42,501,513.31 year-on-year[5] - Basic and diluted earnings per share decreased by 47.37% to ¥0.20 from ¥0.38 in the same period last year[5] - Total operating revenue for Q1 2023 was CNY 213,051,602.08, a decrease of 26% compared to CNY 287,553,976.89 in the same period last year[17] - Net profit for Q1 2023 was CNY 22,831,022.41, a decline of 46% compared to CNY 42,501,513.31 in Q1 2022[19] - The total comprehensive income for Q1 2023 was CNY 22,099,180.34, a decrease from CNY 42,271,901.04 in the previous year[19] - The total comprehensive income attributable to the parent company was CNY 22,099,180.34, a decrease from CNY 42,271,901.04 in the previous period, representing a decline of approximately 47.8%[20] Cash Flow - The net cash flow from operating activities increased by 9.17% to ¥70,500,402.26, compared to ¥64,581,083.69 in the previous year[5] - Cash inflow from operating activities totaled CNY 268,189,209.89, compared to CNY 348,411,849.62 in the previous period, indicating a decrease of about 23.0%[20] - The net cash flow from operating activities was CNY 70,500,402.26, an increase from CNY 64,581,083.69 in the previous period, showing an increase of approximately 9.0%[20] - Cash inflow from investment activities was CNY 677,179,555.56, significantly higher than CNY 273,594,110.98 in the previous period, marking an increase of about 147.0%[21] - The net cash flow from investment activities was CNY 145,219,155.86, compared to CNY 125,838,731.12 in the previous period, reflecting an increase of approximately 15.4%[21] - Cash inflow from financing activities was CNY 1,129,907.20, down from CNY 8,916,824.00 in the previous period, indicating a decrease of about 87.3%[21] - The net increase in cash and cash equivalents was CNY 201,991,540.72, compared to CNY 198,393,325.28 in the previous period, showing a slight increase of approximately 1.3%[21] - The ending balance of cash and cash equivalents was CNY 939,477,711.71, up from CNY 467,620,590.64 in the previous period, representing an increase of about 100.5%[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,809,936,875.51, a slight increase of 0.55% from ¥1,800,040,073.26 at the end of the previous year[5] - Total liabilities decreased to CNY 385,814,529.22 from CNY 400,781,967.05 in the previous period[16] - The company's equity attributable to shareholders increased to CNY 1,424,122,346.29 from CNY 1,399,258,106.21[16] - The total current assets at the end of Q1 2023 were RMB 1.59 billion, slightly up from RMB 1.58 billion at the beginning of the year, indicating a marginal increase of about 0.9%[14] Investments and Other Financial Metrics - Investment income increased by 50.45% to ¥1,601,673.61, compared to ¥1,064,570.35 in the previous year, attributed to higher returns from bank financial products[7] - The company reported a significant decrease in trading financial assets by 52.18%, from ¥301,128,182.93 to ¥144,003,401.84, primarily due to the maturity of financial products[7] - The company's trading financial assets decreased to RMB 144 million from RMB 301 million, reflecting a decline of approximately 52.1%[14] - Accounts receivable stood at RMB 180.73 million, down from RMB 202.41 million, showing a decrease of about 10.7%[14] - The company reported inventory of RMB 206.12 million, down from RMB 219.64 million, which is a decrease of approximately 6.2%[14] - The company’s other receivables rose to RMB 3.84 million from RMB 3.33 million, reflecting an increase of about 15.3%[14] Shareholder Information and Fundraising - The total number of ordinary shareholders at the end of the reporting period was 12,061[9] - The company plans to raise a total of up to RMB 790 million through a private placement to no more than 35 specific investors[12] - The company has received approval from the board and shareholders for the issuance of A-shares, pending regulatory approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission[13] - The company is currently in the process of regulatory approvals for its stock issuance, which may affect the timing and execution of the fundraising[13] Research and Development - Research and development expenses for Q1 2023 were CNY 15,529,525.01, down from CNY 17,689,705.81 in the same quarter last year[17] Foreign Exchange and Other Losses - The company reported a foreign exchange loss of CNY 731,842.07 in Q1 2023, compared to a loss of CNY 229,612.27 in Q1 2022[19] Audit Status - The first quarter report was not audited[21]